參考文獻(xiàn)/References:
[1] LAMB J N,HOLTON C,O'CONNOR P,et al.Avascular necrosis of the hip[J].BMJ,2019,365:l2178.
[2] KRENN V,MÜLLER S,KRENN V T,et al.Pathophysiology of aseptic femoral head necrosis:Pathogenesis and histo-pathological differential diagnosis[J].Orthopade,2018,47(9):710-716.
[3] 中國醫(yī)師協(xié)會骨科醫(yī)師分會骨循環(huán)與骨壞死專業(yè)委員會,中華醫(yī)學(xué)會骨科分會骨顯微修復(fù)學(xué)組,國際骨循環(huán)學(xué)會中國區(qū).中國成人股骨頭壞死臨床診療指南(2020)[J].中華骨科雜志,2020,40(20):1365-1376.
[4] 魏秋實,楊帆,陳嘵俊,等.激素性與酒精性股骨頭壞死患者骨標(biāo)本壞死區(qū)域病理與顯微結(jié)構(gòu)特點分析[J].中國修復(fù)重建外科雜志,2018,32(7):866-872.
[5] 中華醫(yī)學(xué)會骨科學(xué)分會關(guān)節(jié)外科學(xué)組.股骨頭壞死臨床診療規(guī)范[J].中國矯形外科雜志,2016,24(1):49-54.
[6] GARDENIERS J W M.A new international classification of osteonecrosis of the ARCO committee on terminology and classification[J].ARCO News Letter,1992,4:41-46.
[7] 何偉.精確診斷前提下股骨頭壞死非手術(shù)治療實踐[J].臨床外科雜志,2017,25(8):580-582.
[8] 劉芳,黃海,楊槐,等.骨質(zhì)疏松性股骨頸骨折掃描電鏡觀察[J].廣東醫(yī)學(xué),2010,31(7):843-845.
[9] NANGO N,KUBOTA S,HASEGAWA T,et al.Osteocyte-directed bone demineralization along canaliculi[J].Bone,2016,84:279-288.
[10] SASAKI M,KUROSHIMA S,AOKI Y,et al.Ultrastructural alterations of osteocyte morphology via loaded implants in rabbit tibiae[J].J Biomech,2015,48(15):4130-4141.
[11] KUSUMBE A P,RAMASAMY S K,ADAMS R H.Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J].Nature,2014,507(7492):323-328.
[12] CHIM S M,TICKNER J,CHOW S T,et al.Angiogenic factors in bone local environment[J].Cytokine Growth Factor Rev,2013,24(3):297-310.
[13] GAO S Y,LIN R B,HUANG S H,et al.PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis[J].Bone,2021,144:115117.
[14] RAHMAN M M,MATSUOKA K,TAKESHITA S,et al.Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs[J].Biochem Biophys Res Commun,2015,462(2):159-164.
[15] XIE H,CUI Z,WANG L,et al.PDGF-BB secreted by pre-osteoclasts induces angiogenesis during coupling with osteogenesis[J].Nat Med,2014,20(11):1270-1278.
[16] 沈瑩姍,何曉銘,趙雄,等.關(guān)于“血瘀證是股骨頭壞死主要證候”的調(diào)查研究[J].中醫(yī)正骨,2022,34(4):25-29.
[17] 徐傳毅.袁浩教授從血瘀證論治激素性股骨頭壞死經(jīng)驗[J].中醫(yī)藥學(xué)刊,2003,21(2):194-195.
[18] 何偉,徐傳毅,李雄,等.酒精性股骨頭壞死血液流變學(xué)改變及意義[J].中醫(yī)正骨,2001,13(10):8-9.
[19] 中華中醫(yī)藥學(xué)會.股骨頭壞死中醫(yī)辨證標(biāo)準(zhǔn)(2019年版)[J].中醫(yī)正骨,2019,31(6):1-2.
[20] 吳以嶺,賈振華,常麗萍,等.脈絡(luò)學(xué)說營衛(wèi)理論指導(dǎo)血管病變防治研究[J].中國實驗方劑學(xué)雜志,2019,25(1):1-10.
[21] 吳以嶺.“脈絡(luò)-血管系統(tǒng)”相關(guān)性探討[J].中醫(yī)雜志,2007,48(1):5-8.
[22] 吳相春,來靜,吳以嶺,等.絡(luò)氣郁滯證候?qū)ρ軆?nèi)皮的作用及機(jī)制研究[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2009,15(11):823-824.
[23] 賈振華,高懷林,谷春華,等.基于3469 例血管病變患者證候分布規(guī)律的脈絡(luò)病變共性病機(jī)探討[J].中醫(yī)雜志,2009,50(10):920-924.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):20.
[11]簡羿,馬茂瀟,郭珈宜,等.基于多重免疫組化技術(shù)探討股骨頭壞死愈膠囊治療激素性股骨頭壞死的作用機(jī)制[J].中醫(yī)正骨,2024,36(02):23.
JIAN Yi,MA Maoxiao,GUO Jiayi,et al.The mechanism of Gugutou Huaisiyu Jiaonang(股骨頭壞死愈膠囊)in treatment of steroid-induced osteonecrosis of femoral head:a multiplex immunohistochemistry technique-based experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(05):23.